Interpace Biosciences

Interpace Biosciences (IDXG) is a dynamic and growing leader in the life sciences industry, providing complex molecular analyses for the early diagnosis and treatment of cancer, and supporting the development of targeted therapeutic agents. Since its establishment, we have helped doctors diagnose and treat more than 75,000 patients and have contributed to many of the most critical clinical trials in the pharmaceutical and biotechnology industries.